Cancer Treatment Reviews - Search Results

313 Periodical Search Results
You searched for "adjuvant" OR "immunostimulant" OR "adjuvants, immunologic" OR "adjuvants, pharmaceutic" OR "immune enhancement agent" within Cancer Treatment Reviews
New Search \| Edit Search \| Save Search \| Save Search as an E-mail Alert
Viewing 1-20 of 313 results Next 20>	Results Page: [1] 2 3 4 5 6 7 >

Display:

	Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: A systematic review and meta-analysis of randomised trials , 03 June 2009 M.D. Shelley, S. Kumar, B. Coles, T. Wilt, J. Staffurth, M.D. Mason Cancer Treatment Reviews November 2009 (Vol. 35, Issue 7, Pages 540-546) Abstract \| Full Text \| Full-Text PDF (626 KB)
	Chemotherapy for operable and advanced colorectal cancer , 01 June 2009 Carlo Aschele, Francesca Bergamo, Sara Lonardi Cancer Treatment Reviews October 2009 (Vol. 35, Issue 6, Pages 509-516) Abstract \| Full Text \| Full-Text PDF (182 KB)
	Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer Corrected Proof, 07 September 2009 Mohamed Hebbar, François-René Pruvot, Olivier Romano, Jean-Pierre Triboulet, Aimery de Gramont Cancer Treatment Reviews DOI: 10.1016/j.ctrv.2009.08.005 Abstract \| Full Text \| Full-Text PDF (201 KB)
	Lapatinib: A competitor or companion to trastuzumab? , 14 September 2009 D. Collins, A.D.K. Hill, L. Young Cancer Treatment Reviews November 2009 (Vol. 35, Issue 7, Pages 574-581) Abstract \| Full Text \| Full-Text PDF (289 KB)
	Management of primary and advanced breast cancer in older unfit patients (medical treatment) , 17 September 2009 M. Aapro, Silvio Monfardini, Antonio Jirillo, Umberto Basso Cancer Treatment Reviews October 2009 (Vol. 35, Issue 6, Pages 503-508) Abstract \| Full Text \| Full-Text PDF (167 KB)
	Adjuvant docetaxel plus doxorubicin and cyclophosphamide increases survival compared with fluorouracil plus doxorubicin and cyclophosphamide in women with operable node-positive breast cancer , 23 January 2006 Vivek Roy, Edith A. Perez Cancer Treatment Reviews February 2006 (Vol. 32, Issue 1, Pages 55-58) Full Text \| Full-Text PDF (74 KB)
	No clear evidence for adjuvant therapy in people with stage II colon cancer: Abstracted from: Figueredo A, Charette ML, Maroun J et al. Adjuvant therapy for stage II colon cancer: A systematic review from the Cancer Care Ontario Program in evidence-based care’s gastrointestinal cancer disease site group. J Clin Oncol 2004; 22: 3395–407. , 22 March 2005 Peer Wille-Jørgensen Cancer Treatment Reviews April 2005 (Vol. 31, Issue 2, Pages 147-150) Full Text \| Full-Text PDF (79 KB)
	Adjuvant chemotherapy with uracil–tegafur prolongs overall survival in people with primary adenocarcinoma of the lung: Abstracted from: Kato H, Ichinose Y, Ohta M, et al. A randomized trial of adjuvant chemotherapy with uracil–tegafur for adenocarcinoma of the lung. N Engl J Med 2004;350:1713–21. WK (Bill) Evans Cancer Treatment Reviews November 2004 (Vol. 30, Issue 7, Pages 661-664) Full Text \| Full-Text PDF (237 KB)
	Adjuvant radiation therapy for colon cancer Bruce D. Minsky Cancer Treatment Reviews September 1995 (Vol. 21, Issue 5, Pages 407-414) Abstract \| Abstract + References \| Full-Text PDF (468 KB)
	Adjuvant treatment of colorectal cancer R.S. Midgley, D.J. Kerr Cancer Treatment Reviews May 1997 (Vol. 23, Issue 3, Pages 135-152) Abstract + References \| Full-Text PDF (1382 KB)
	The role of topoisomerase IIα and HER-2 in predicting sensitivity to anthracyclines in breast cancer patients Corrected Proof, 16 September 2009 Catherine Oakman, Erica Moretti, Francesca Galardi, Libero Santarpia, Angelo Di Leo Cancer Treatment Reviews DOI: 10.1016/j.ctrv.2009.08.006 Abstract \| Full Text \| Full-Text PDF (238 KB)
	Effects of adjuvant chemotherapy on the natural history and likelihood of therapeutic efficacy in advanced breast cancer patients: a critical literature review Jérôme Alexandre, Sandrine Faivre, William Sutherland, Esteban Cvitkovic Cancer Treatment Reviews December 1998 (Vol. 24, Issue 6, Pages 393-406) Abstract + References \| Full-Text PDF (1505 KB)
	New approaches to the systemic treatment of melanoma S. Chowdhury, M.M. Vaughan, M.E. Gore Cancer Treatment Reviews October 1999 (Vol. 25, Issue 5, Pages 259-270) Abstract \| Abstract + References \| Full-Text PDF (182 KB)
	Combined chemo-endocrine adjuvant therapy for patients with operable breast cancer: Still a question? M. Colleoni, A. Coates, O. Pagani, A. Goldhirsch Cancer Treatment Reviews February 1998 (Vol. 24, Issue 1, Pages 15-26) Abstract + References \| Full-Text PDF (1364 KB)
	Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer , 15 November 2005 C. Lamberti, T. Sauerbruch, A Glasmacher Cancer Treatment Reviews December 2005 (Vol. 31, Issue 8, Pages 648-652) Full Text \| Full-Text PDF (81 KB)
	Immunochemotherapy with OK-432 may improve survival for people with curatively resected gastric cancer: Abstracted from: Sakamoto J, Teramukai S, Nakazato H et al. Efficacy of adjuvant immunochemotherapy with OK-432 for patients with curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials. Journal of Immunotherapy 2002; 25: 405–12. Ilaria Panzini, Lorenzo Gianni, Davide Tassinari Cancer Treatment Reviews February 2003 (Vol. 29, Issue 1, Pages 73-75) Full Text \| Full-Text PDF (67 KB)
	Adding temozolomide to radiotherapy prolongs survival in people with glioblastoma: Abstracted from: Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–96. , 19 October 2005 Alba A. Brandes Cancer Treatment Reviews November 2005 (Vol. 31, Issue 7, Pages 577-581) Full Text \| Full-Text PDF (76 KB)
	Sequential paclitaxel reduces recurrence and mortality in women with early breast cancer Aman U Buzdar, Gabriel N Hortobagyi Cancer Treatment Reviews October 2003 (Vol. 29, Issue 5, Pages 449-452) Full Text \| Full-Text PDF (76 KB)
	Trastuzumab after primary treatment for early stage HER2-positive breast cancer reduces recurrence , 07 March 2006 Rebecca Dent, Mark Clemons Cancer Treatment Reviews April 2006 (Vol. 32, Issue 2, Pages 144-148) Full Text \| Full-Text PDF (80 KB)
	Switching to exemestane after 2–3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen: Abstracted from: Coombes RC, Hall E, Gibson LJ, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004;350:1081–92. Christina Davies Cancer Treatment Reviews October 2004 (Vol. 30, Issue 6, Pages 583-588) Full Text \| Full-Text PDF (248 KB)

Display:

Viewing 1-20 of 313 results Next 20>	Results Page: [1] 2 3 4 5 6 7 >
New Search \| Edit Search \| Save Search \| Save Search as an E-mail Alert